Related Experiment Video

Updated: Aug 22, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.6K

Reduced IQGAP2 Promotes Bladder Cancer through Regulation of MAPK/ERK Pathway and Cytokines

Fei Song1, Roland Kotolloshi1, Mieczyslaw Gajda2

  • 1Department of Urology, Jena University Hospital, 07740 Jena, Germany.

International Journal of Molecular Sciences
|November 11, 2022
PubMed

Insights

IQGAP2 is downregulated in bladder cancer, suppressing tumor growth and preventing progression. Reduced IQGAP2 promotes metastasis by activating the MAPK/ERK pathway, indicating its tumor-suppressive role.

Area of Science:

  • Urologic Oncology
  • Molecular Oncology
  • Cancer Biology

Background:

  • Progression from non-muscle-invasive bladder cancer (NMIBC) to muscle-invasive bladder cancer (MIBC) is a significant clinical challenge.
  • Molecular mechanisms driving bladder cancer progression are not fully understood.
  • IQ motif containing GTPase activating protein 2 (IQGAP2) dysregulation is observed in various cancers and implicated in oncogenic pathways.

Purpose of the Study:

  • To investigate the role of IQGAP2 in bladder cancer.
  • To determine the impact of IQGAP2 on bladder cancer cell growth, epithelial-mesenchymal transition (EMT), and related signaling pathways.

Main Methods:

  • Comparative analysis of IQGAP2 expression in bladder tumor tissues and normal urothelium.
  • Assessment of IQGAP2's effect on bladder cancer cell proliferation and apoptosis.
  • Investigation of IQGAP2's influence on EMT induction via the MAPK/ERK pathway.
  • Evaluation of IQGAP2's role in regulating cytokine expression and cellular processes like proliferation and metastasis.

Main Results:

  • IQGAP2 expression was significantly downregulated in bladder tumors compared to normal urothelial tissues and cells.
  • IQGAP2 attenuated bladder cancer cell growth without inducing apoptosis.
  • Downregulation of IQGAP2 promoted EMT in bladder cancer cells through activation of the MAPK/ERK pathway.
  • IQGAP2 may regulate key cellular processes, including proliferation and metastasis, via cytokine modulation.

Conclusions:

  • IQGAP2 functions as a tumor suppressor in bladder cancer.
  • Inhibition of the MAPK/ERK pathway and reduction of cytokines are potential mechanisms for IQGAP2's tumor-suppressive activity.
  • IQGAP2 warrants further investigation as a potential therapeutic target in bladder cancer.
Keywords:
IQGAP2MEK/ERK signalingbladder cancercancer progressiontumor suppressor

More Related Videos

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

631
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.3K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K